What is the address of GASTON HENROTAUX - CARDIOLOGIE?

The registered office of GASTON HENROTAUX - CARDIOLOGIE is located at Rue Grandzée(PLX) 4, 4122 Neupré.

Is GASTON HENROTAUX - CARDIOLOGIE still active?

Yes. According to the CBE (2 November 2026) GASTON HENROTAUX - CARDIOLOGIE is active, legal situation “Normale toestand”, started on 2 March 2001.

Is GASTON HENROTAUX - CARDIOLOGIE registered on Peppol?

No, GASTON HENROTAUX - CARDIOLOGIE is currently not registered on the Peppol network.

What is the enterprise number of GASTON HENROTAUX - CARDIOLOGIE?

The enterprise number of GASTON HENROTAUX - CARDIOLOGIE is BE0474228545.

When was GASTON HENROTAUX - CARDIOLOGIE founded?

GASTON HENROTAUX - CARDIOLOGIE was founded on 2 March 2001.

Who are the directors of GASTON HENROTAUX - CARDIOLOGIE?

According to the 2025 annual accounts, the directors of GASTON HENROTAUX - CARDIOLOGIE are: Gaston Henrotaux.

Is GASTON HENROTAUX - CARDIOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 March 2001; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GASTON HENROTAUX - CARDIOLOGIE make in 2025?

GASTON HENROTAUX - CARDIOLOGIE posted a profit after taxes of € 49,898 in financial year 2025.

What is the revenue of GASTON HENROTAUX - CARDIOLOGIE?

As a small company, GASTON HENROTAUX - CARDIOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 78,966.

GASTON HENROTAUX - CARDIOLOGIE (Private Limited) - Neupré

Dossier GASTON HENROTAUX - CARDIOLOGIE, printed on 2 November 2026 from databakkes.be/en/0474228545/gaston-henrotaux-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

GASTON HENROTAUX - CARDIOLOGIE from Neupré, company number BE0474228545, closed financial year 2025 with a result of € 49,898 after tax. For that financial year GASTON HENROTAUX - CARDIOLOGIE recorded a gross margin of € 78,966 and equity of € 256,562. Compared with financial year 2024, the result moved from € 58,080 to € 49,898. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 10, 2026.

What it is worth Healthy

€ 256,562

▼ 21% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 49,898

▼ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 295,089

▼ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 120,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 458

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 86,394 Gross margin 2022: € 86,394 First fiscal year in the series	€ 79,955 Gross margin 2023: € 79,955 ▼ 7% vs 2022 (€ 86,394) Unfavourable step	€ 92,377 Gross margin 2024: € 92,377 ▲ 16% vs 2023 (€ 79,955) Favourable step	€ 78,966 Gross margin 2025: € 78,966 ▼ 15% vs 2024 (€ 92,377) Unfavourable step	▼ 15%
Profit after taxes	€ 55,892 Profit after taxes 2022: € 55,892 First fiscal year in the series	€ 50,219 Profit after taxes 2023: € 50,219 ▼ 10% vs 2022 (€ 55,892) Unfavourable step	€ 58,080 Profit after taxes 2024: € 58,080 ▲ 16% vs 2023 (€ 50,219) Favourable step	€ 49,898 Profit after taxes 2025: € 49,898 ▼ 14% vs 2024 (€ 58,080) Unfavourable step	▼ 14%
Equity	€ 311,364 Equity 2022: € 311,364 First fiscal year in the series	€ 311,583 Equity 2023: € 311,583 Unchanged (€ 311,364) Favourable step	€ 326,663 Equity 2024: € 326,663 ▲ 5% vs 2023 (€ 311,583) Favourable step	€ 256,562 Equity 2025: € 256,562 ▼ 21% vs 2024 (€ 326,663) Unfavourable step	▼ 21%
Total debts	€ 32,557 Total debts 2022: € 32,557 First fiscal year in the series	€ 50,917 Total debts 2023: € 50,917 ▲ 56% vs 2022 (€ 32,557) Unfavourable step	€ 43,839 Total debts 2024: € 43,839 ▼ 14% vs 2023 (€ 50,917) Favourable step	€ 56,745 Total debts 2025: € 56,745 ▲ 29% vs 2024 (€ 43,839) Unfavourable step	▲ 29%
Cash	€ 243,825 Cash 2022: € 243,825 First fiscal year in the series	€ 268,081 Cash 2023: € 268,081 ▲ 10% vs 2022 (€ 243,825) Favourable step	€ 309,978 Cash 2024: € 309,978 ▲ 16% vs 2023 (€ 268,081) Favourable step	€ 295,089 Cash 2025: € 295,089 ▼ 5% vs 2024 (€ 309,978) Unfavourable step	▼ 5%
Land & buildings	€ 2,953 Land & buildings 2022: € 2,953 First fiscal year in the series	€ 1,476 Land & buildings 2023: € 1,476 ▼ 50% vs 2022 (€ 2,953) Unchanged	-	-
Retained profit	€ 298,964 Retained profit 2022: € 298,964 First fiscal year in the series	€ 299,183 Retained profit 2023: € 299,183 Unchanged (€ 298,964) Favourable step	€ 314,263 Retained profit 2024: € 314,263 ▲ 5% vs 2023 (€ 299,183) Favourable step	€ 244,162 Retained profit 2025: € 244,162 ▼ 22% vs 2024 (€ 314,263) Unfavourable step	▼ 22%
Dividend	€ 30,000 Dividend 2022: € 30,000 First fiscal year in the series	€ 50,000 Dividend 2023: € 50,000 ▲ 67% vs 2022 (€ 30,000) Unchanged	€ 43,000 Dividend 2024: € 43,000 ▼ 14% vs 2023 (€ 50,000) Unchanged	€ 120,000 Dividend 2025: € 120,000 ▲ 179% vs 2024 (€ 43,000) Unchanged	▲ 179%
Balance sheet total	€ 343,921 Balance sheet total 2022: € 343,921 First fiscal year in the series	€ 362,500 Balance sheet total 2023: € 362,500 ▲ 5% vs 2022 (€ 343,921) Unchanged	€ 370,502 Balance sheet total 2024: € 370,502 ▲ 2% vs 2023 (€ 362,500) Unchanged	€ 313,307 Balance sheet total 2025: € 313,307 ▼ 15% vs 2024 (€ 370,502) Unchanged	▼ 15%

Key figures of GASTON HENROTAUX - CARDIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GASTON HENROTAUX - CARDIOLOGIE?

What happened at GASTON HENROTAUX - CARDIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2027 Gaston Henrotaux stepped down as director. NBB
May 10, 2026 New annual accounts for financial year 2025: profit of € 49,898 (▼ 14% vs 2024). Source: NBB ↗
2012 Gaston Henrotaux became a director. NBB
Mar 2, 2001 New establishment in Neupré. KBO
Mar 2, 2001 Start of the company according to the CBE. KBO

In short

From € 55,892 profit in 2022 to € 49,898 profit in 2025.

Paid € 105,709 in corporate taxes since 2022.

Best year ever: 2024, with € 58,080 profit.

Paid out € 243,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Gaston Henrotaux

Director

since 2012 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Grandzée(PLX) 4

4122 Neupré

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0474.228.545
VAT number: BE 0474.228.545
Registered office: Rue Grandzée(PLX) 4, 4122 Neupré
Names & denominations: GASTON HENROTAUX - CARDIOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 March 2001
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗

GASTON HENROTAUX - CARDIOLOGIE